Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis

OBJECTIVES: Extended-release (ER) carbidopa-levodopa (CD-LD) (IPX066/RYTARY/NUMIENT) produces improvements in “off” time, “on” time without troublesome dyskinesia, and Unified Parkinson Disease Rating Scale scores compared with immediate-release (IR) CD-LD or IR CD-LD plus entacapone (CLE). Post hoc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Neuropharmacol
Main Authors: LeWitt, Peter A., Verhagen Metman, Leo, Rubens, Robert, Khanna, Sarita, Kell, Sherron, Gupta, Suneel
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2018
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865491/
https://ncbi.nlm.nih.gov/pubmed/29432286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WNF.0000000000000269
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares